Webinar
29 Mar 2022

Webinar - The Development of Nanosuspension Formulations for Poorly Soluble Drugs

Complimentary webinar on nanomilling, a game-changing technology to resolve solubility issues while providing increased bioavailability for oral, topical, transmucosal, and injectable delivery. 

Topics covered include:

  • Uses and benefits of nanomilling
  • Equipment specific to nanomilling 
  • Types of milling media and stabilizers
  • Scale-up and clinical manufacturing 



 At Altasciences, our experts in pharmaceutical contract manufacturing are ready to support you in formulation, validation, commercial batches, and controlled substances. We have tested or manufactured almost all available dosage forms on the market, including liquid- and powder-filled capsules, nanomilled suspensions, creams, gels, tablets, and terminally sterilized injectables. Analytical services include development and validation of methodologies, and a range of product-release testing. Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. Our full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. We help sponsors get better drugs to the people who need them, faster. 


 Learn more about our manufacturing and analytical solutions: https://www.altasciences.com/manufacturing-and-analytical-services 


 To discover our full range of integrated solutions, visit: https://www.altasciences.com

Content provided by our supplier

Altasciences

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator

Other Content from Altasciences (3)

  • News Altasciences acquires Sinclair Research and continues to expand pre-clinical platform

    Laval, Quebec, January 4, 2022 – Altasciences, an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a seamless solution to early-stage drug development from lead candidate selection to clinical proof of concept, announced today the completed acquisition of Sinclair Research, a preclinical CRO located in the Midwest. Complementing existing locations on the East and West Coast, the new site will facilitate even greater access to Altasciences’ preclinical services across the U.S.
  • Brochure Altasciences Manufacturing and Analytical Services

    We provide proof of concept, R&D, clinical and commercial manufacturing, that includes liquid-filled capsules, band/sealing technologies, powder and over-encapsulated capsules, topical formulations, and clinical and blister packaging, manufactured in our purpose-built facility that includes state-of-the-art ISO 7 and ISO 8 cleanrooms. 
  • Podcast QUICK CHAT with Ben Reed — Speed and Quality in Drug Manufacturing

    Discover how Altasciences' CDMO services set the foundation for quality and expertise. In a new interview, Vice President of Manufacturing, Ben Reed, discusses Altasciences' unique drug manufacturing capabilities, talent acquisition, and running niche programs.